Site Members can sign up for company wide alerts
Investigation Overview
June 15, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Albany Molecular Research, Inc. (NASDAQ:AMRI), was announced concerning whether the takeover of Albany Molecular Research, Inc. by The Carlyle Group and GTCR LLC for $21.75 per share is unfair to NASDAQ:AMRI stockholders. The investigation by a law firm concerns whether cert...
You must register (for free) or login to view the entire investigation.